Literature DB >> 29602445

Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment.

María T Elola1, Fátima Ferragut2, Santiago P Méndez-Huergo3, Diego O Croci4, Candelaria Bracalente2, Gabriel A Rabinovich5.   

Abstract

Tumor cells corrupt surrounding normal cells instructing them to support proliferative, pro-angiogenic and immunosuppressive networks that favor tumorigenesis and metastasis. This dynamic cross-talk is sustained by a range of intracellular signals and extracellular mediators produced by both tumoral and non-tumoral cells. Galectins -whether secreted or intracellularly expressed- play central roles in the tumorigenic process by delivering regulatory signals that contribute to reprogram fibroblasts, endothelial and immune cell programs. Through glycosylation-dependent or independent mechanisms, these endogenous lectins control a variety of cellular events leading to tumor cell proliferation, survival, migration, inflammation, angiogenesis and immune escape. Here we discuss the role of galectin-driven pathways, particularly those activated in non-tumoral stromal cells, in modulating tumor progression.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endothelial cells; Fibroblasts; Galectins; Immune cells; Tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 29602445     DOI: 10.1016/j.cellimm.2018.03.008

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  22 in total

1.  "Stuck on sugars - how carbohydrates regulate cell adhesion, recognition, and signaling".

Authors:  Richard D Cummings
Journal:  Glycoconj J       Date:  2019-07-02       Impact factor: 2.916

2.  Understanding a complicated Gal-1.

Authors:  Angela C Hirbe; David H Gutmann
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

3.  The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins.

Authors:  Stacy A Malaker; Kayvon Pedram; Michael J Ferracane; Barbara A Bensing; Venkatesh Krishnan; Christian Pett; Jin Yu; Elliot C Woods; Jessica R Kramer; Ulrika Westerlind; Oliver Dorigo; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-25       Impact factor: 11.205

4.  Expression Pattern and Immunoregulatory Roles of Galectin-1 and Galectin-3 in Atopic Dermatitis and Psoriasis.

Authors:  Mab P Corrêa; Rebeca D Correia-Silva; Gisela R Silva Sasso; Solange C G P D'Ávila; Karin V Greco; Sonia M Oliani; Cristiane D Gil
Journal:  Inflammation       Date:  2022-01-15       Impact factor: 4.092

5.  The Expression of Galectin-3 in Tumor and Cancer-Associated Fibroblasts in Invasive Micropapillary Breast Carcinomas: Relationship with Clinicopathologic Parameters.

Authors:  Yasemin Çakır; Canan Kelten Talu; Özlem Mermut; Didem Can Trabulus; Esra Arslan
Journal:  Eur J Breast Health       Date:  2021-10-04

6.  Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma.

Authors:  Sibin Zhang; Xu Xiao; Yu Wang; Tianjun Song; Chenlong Li; Hongbo Bao; Qing Liu; Guiyin Sun; Xiaoyang Sun; Tianqi Su; Tianjiao Fu; Yujie Wang; Peng Liang
Journal:  Front Genet       Date:  2022-06-02       Impact factor: 4.772

7.  PI3K/AKT/mTOR Pathway-Associated Genes Reveal a Putative Prognostic Signature Correlated with Immune Infiltration in Hepatocellular Carcinoma.

Authors:  Zhihuai Wang; Adeel Ur Rehman; Xihu Qin; Chunfu Zhu; Siyuan Wu
Journal:  Dis Markers       Date:  2022-05-09       Impact factor: 3.464

8.  An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.

Authors:  Yifei Dai; Weijie Qiang; Kequan Lin; Yu Gui; Xun Lan; Dong Wang
Journal:  Cancer Immunol Immunother       Date:  2020-10-21       Impact factor: 6.968

Review 9.  Glycan Microarrays as Chemical Tools for Identifying Glycan Recognition by Immune Proteins.

Authors:  Chao Gao; Mohui Wei; Tanya R McKitrick; Alyssa M McQuillan; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Front Chem       Date:  2019-12-13       Impact factor: 5.221

Review 10.  Immunopathology of galectin-3: an increasingly promising target in COVID-19.

Authors:  John L Caniglia; Swapna Asuthkar; Andrew J Tsung; Maheedhara R Guda; Kiran K Velpula
Journal:  F1000Res       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.